Completion of the human papillomavirus (HPV) vaccine series among males with private insurance between 2006 and 2009

Jacqueline Hirth, Alai Tan, Gregg S. Wilkinson, Abbey Berenson

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Little is known about initiation and completion among males who received the HPV vaccine on an off-label basis before 2009. This study utilized administrative claims data from a private insurance company to examine completion of the 3 dose HPV series among 514 males who initiated the vaccine between 2006 and May of 2009. Frequencies of HPV vaccination were examined and multivariate logistic regression estimated the odds of completing the entire series within 365 days of initiation. We found that only 21% of male initiators completed all 3 vaccine doses within 12 months and completion decreased over time. Series completion did not vary significantly by provider type. These findings suggest that difficulties may be encountered in fully vaccinating enough males to achieve adequate herd immunity in the future.

Original languageEnglish
Pages (from-to)1138-1140
Number of pages3
JournalVaccine
Volume31
Issue number8
DOIs
StatePublished - Feb 6 2013

Fingerprint

Papillomavirus Vaccines
Papillomaviridae
insurance
Insurance
vaccines
Vaccines
Herd Immunity
dosage
Vaccination
Logistic Models
vaccination

Keywords

  • HPV vaccines
  • Human papillomavirus
  • Human papillomavirus vaccine L1
  • Male HPV vaccine series completion
  • Papillomavirus vaccines

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)
  • Molecular Medicine

Cite this

Completion of the human papillomavirus (HPV) vaccine series among males with private insurance between 2006 and 2009. / Hirth, Jacqueline; Tan, Alai; Wilkinson, Gregg S.; Berenson, Abbey.

In: Vaccine, Vol. 31, No. 8, 06.02.2013, p. 1138-1140.

Research output: Contribution to journalArticle

@article{486ed02c11ae489ba6a814443235619e,
title = "Completion of the human papillomavirus (HPV) vaccine series among males with private insurance between 2006 and 2009",
abstract = "Little is known about initiation and completion among males who received the HPV vaccine on an off-label basis before 2009. This study utilized administrative claims data from a private insurance company to examine completion of the 3 dose HPV series among 514 males who initiated the vaccine between 2006 and May of 2009. Frequencies of HPV vaccination were examined and multivariate logistic regression estimated the odds of completing the entire series within 365 days of initiation. We found that only 21{\%} of male initiators completed all 3 vaccine doses within 12 months and completion decreased over time. Series completion did not vary significantly by provider type. These findings suggest that difficulties may be encountered in fully vaccinating enough males to achieve adequate herd immunity in the future.",
keywords = "HPV vaccines, Human papillomavirus, Human papillomavirus vaccine L1, Male HPV vaccine series completion, Papillomavirus vaccines",
author = "Jacqueline Hirth and Alai Tan and Wilkinson, {Gregg S.} and Abbey Berenson",
year = "2013",
month = "2",
day = "6",
doi = "10.1016/j.vaccine.2012.12.051",
language = "English",
volume = "31",
pages = "1138--1140",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "8",

}

TY - JOUR

T1 - Completion of the human papillomavirus (HPV) vaccine series among males with private insurance between 2006 and 2009

AU - Hirth, Jacqueline

AU - Tan, Alai

AU - Wilkinson, Gregg S.

AU - Berenson, Abbey

PY - 2013/2/6

Y1 - 2013/2/6

N2 - Little is known about initiation and completion among males who received the HPV vaccine on an off-label basis before 2009. This study utilized administrative claims data from a private insurance company to examine completion of the 3 dose HPV series among 514 males who initiated the vaccine between 2006 and May of 2009. Frequencies of HPV vaccination were examined and multivariate logistic regression estimated the odds of completing the entire series within 365 days of initiation. We found that only 21% of male initiators completed all 3 vaccine doses within 12 months and completion decreased over time. Series completion did not vary significantly by provider type. These findings suggest that difficulties may be encountered in fully vaccinating enough males to achieve adequate herd immunity in the future.

AB - Little is known about initiation and completion among males who received the HPV vaccine on an off-label basis before 2009. This study utilized administrative claims data from a private insurance company to examine completion of the 3 dose HPV series among 514 males who initiated the vaccine between 2006 and May of 2009. Frequencies of HPV vaccination were examined and multivariate logistic regression estimated the odds of completing the entire series within 365 days of initiation. We found that only 21% of male initiators completed all 3 vaccine doses within 12 months and completion decreased over time. Series completion did not vary significantly by provider type. These findings suggest that difficulties may be encountered in fully vaccinating enough males to achieve adequate herd immunity in the future.

KW - HPV vaccines

KW - Human papillomavirus

KW - Human papillomavirus vaccine L1

KW - Male HPV vaccine series completion

KW - Papillomavirus vaccines

UR - http://www.scopus.com/inward/record.url?scp=84873086033&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873086033&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2012.12.051

DO - 10.1016/j.vaccine.2012.12.051

M3 - Article

VL - 31

SP - 1138

EP - 1140

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 8

ER -